6dn6 - Revision history

OCA at 10:20, 15 November 2023

2023-11-15T10:20:05Z

←Older revision		Revision as of 10:20, 15 November 2023
Line 3:		Line 3:
	<StructureSection load='6dn6' size='340' side='right'caption='[[6dn6]], [[Resolution\|resolution]] 1.59Å' scene=''>		<StructureSection load='6dn6' size='340' side='right'caption='[[6dn6]], [[Resolution\|resolution]] 1.59Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[6dn6]] is a 2 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Human Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6DN6 OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=6DN6 FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[6dn6]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6DN6 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6DN6 FirstGlance]. <br>
-	</td></tr><tr id='~~NonStdRes~~'><td class="sblockLbl"><b>[[~~Non-Standard_Residue~~\|~~NonStd Res~~:]]</b></td><td class="sblockDat">~~<scene name='pdbligand=ABU:GAMMA~~-~~AMINO-BUTANOIC+ACID'>ABU</scene>~~</td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.59Å</td></tr>
-	<tr id='~~gene~~'><td class="sblockLbl"><b>[[~~Gene~~\|~~Gene~~:]]</b></td><td class="sblockDat">~~SPSB2, GRCC9, SSB2 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode~~=~~Info&srchmode~~=~~5&id=9606 HUMAN])~~</td></tr>	+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ABU:GAMMA-AMINO-BUTANOIC+ACID'>ABU</scene></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=6dn6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6dn6 OCA], [~~http~~://pdbe.org/6dn6 PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=6dn6 RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/6dn6 PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=6dn6 ProSAT]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6dn6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6dn6 OCA], [https://pdbe.org/6dn6 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6dn6 RCSB], [https://www.ebi.ac.uk/pdbsum/6dn6 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6dn6 ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/SPSB2_HUMAN SPSB2_HUMAN]] Probable substrate recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.<ref>PMID:15601820</ref>	+	[https://www.uniprot.org/uniprot/SPSB2_HUMAN SPSB2_HUMAN] Probable substrate recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.<ref>PMID:15601820</ref>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 23:		Line 23:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Human~~]]	+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Caradoc-Davies~~, T T~~]]	+	[[Category: Caradoc-Davies TT]]
-	[[Category: Law~~, R H.P~~]]	+	[[Category: Law RHP]]
-	[[Category: Norton~~, R S]]~~	+	[[Category: Norton RS]]
-	~~[[Category: Immune system]]~~	+
-	~~[[Category: Immune system-inhibitor complex]]~~	+
-	~~[[Category: Inhibitor]]~~	+
-	~~[[Category: Nitric oxide]]~~	+
-	~~[[Category: Proteasomal degradation~~]]	+

OCA at 08:53, 8 January 2020

2020-01-08T08:53:43Z

←Older revision		Revision as of 08:53, 8 January 2020
Line 3:		Line 3:
	<StructureSection load='6dn6' size='340' side='right'caption='[[6dn6]], [[Resolution\|resolution]] 1.59Å' scene=''>		<StructureSection load='6dn6' size='340' side='right'caption='[[6dn6]], [[Resolution\|resolution]] 1.59Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[6dn6]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6DN6 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6DN6 FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[6dn6]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6DN6 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6DN6 FirstGlance]. <br>
	</td></tr><tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=ABU:GAMMA-AMINO-BUTANOIC+ACID'>ABU</scene></td></tr>		</td></tr><tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=ABU:GAMMA-AMINO-BUTANOIC+ACID'>ABU</scene></td></tr>
		+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">SPSB2, GRCC9, SSB2 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6dn6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6dn6 OCA], [http://pdbe.org/6dn6 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6dn6 RCSB], [http://www.ebi.ac.uk/pdbsum/6dn6 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6dn6 ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6dn6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6dn6 OCA], [http://pdbe.org/6dn6 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6dn6 RCSB], [http://www.ebi.ac.uk/pdbsum/6dn6 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6dn6 ProSAT]</span></td></tr>
	</table>		</table>
Line 22:		Line 23:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Human]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
	[[Category: Caradoc-Davies, T T]]		[[Category: Caradoc-Davies, T T]]

OCA at 05:54, 17 April 2019

2019-04-17T05:54:29Z

←Older revision		Revision as of 05:54, 17 April 2019
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 6dn6 is ~~ON HOLD~~ ~~until Paper~~ Publication	+	==SPRY domain-containing SOCS box protein 2 complexed with INNN(ABU) cyclic peptide inhibitor==
		+	<StructureSection load='6dn6' size='340' side='right'caption='[[6dn6]], [[Resolution\|resolution]] 1.59Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[6dn6]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6DN6 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6DN6 FirstGlance]. <br>
		+	</td></tr><tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=ABU:GAMMA-AMINO-BUTANOIC+ACID'>ABU</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6dn6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6dn6 OCA], [http://pdbe.org/6dn6 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6dn6 RCSB], [http://www.ebi.ac.uk/pdbsum/6dn6 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6dn6 ProSAT]</span></td></tr>
		+	</table>
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/SPSB2_HUMAN SPSB2_HUMAN]] Probable substrate recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.<ref>PMID:15601820</ref>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	SPRY domain- and SOCS box-containing proteins SPSB1, SPSB2, and SPSB4 interact with inducible nitric oxide synthase (iNOS), causing the iNOS to be polyubiquitinated and targeted for degradation. Inhibition of this interaction increases iNOS levels, and consequently cellular nitric oxide (NO) concentrations, and has been proposed as a potential strategy for killing intracellular pathogens. We previously described two DINNN-containing cyclic peptides (CP1 and CP2) as potent inhibitors of the murine SPSB-iNOS interaction. In this study, we report the crystal structures of human SPSB4 bound to CP1 and CP2 and human SPSB2 bound to CP2. We then used these structures to design a new inhibitor in which an intramolecular hydrogen bond was replaced with a hydrocarbon linkage to form a smaller macrocycle while maintaining the bound geometry of CP2 observed in the crystal structures. This resulting pentapeptide SPSB-iNOS inhibitor (CP3) has a reduced macrocycle ring size, fewer nonbinding residues, and includes additional conformational constraints. CP3 has a greater affinity for SBSB2 ( KD = 7 nM as determined by surface plasmon resonance) and strongly inhibits the SPSB2-iNOS interaction in macrophage cell lysates. We have also determined the crystal structure of CP3 in complex with human SPSB2, which reveals the structural basis for the increased potency of CP3 and validates the original design.

-	~~Authors~~:	+	A Cyclic Peptide Inhibitor of the iNOS-SPSB Protein-Protein Interaction as a Potential Anti-Infective Agent.,Sadek MM, Barlow N, Leung EWW, Williams-Noonan BJ, Yap BK, Shariff FM, Caradoc-Davies TT, Nicholson SE, Chalmers DK, Thompson PE, Law RHP, Norton RS ACS Chem Biol. 2018 Oct 19;13(10):2930-2938. doi: 10.1021/acschembio.8b00561., Epub 2018 Sep 18. PMID:30226743<ref>PMID:30226743</ref>

-	~~Description~~:	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	[[Category: ~~Unreleased~~ Structures]]	+	</div>
		+	<div class="pdbe-citations 6dn6" style="background-color:#fffaf0;"></div>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Large Structures]]
		+	[[Category: Caradoc-Davies, T T]]
		+	[[Category: Law, R H.P]]
		+	[[Category: Norton, R S]]
		+	[[Category: Immune system]]
		+	[[Category: Immune system-inhibitor complex]]
		+	[[Category: Inhibitor]]
		+	[[Category: Nitric oxide]]
		+	[[Category: Proteasomal degradation]]

OCA at 03:59, 27 June 2018

2018-06-27T03:59:06Z

←Older revision		Revision as of 03:59, 27 June 2018
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 6dn6 is ON HOLD	+	The entry 6dn6 is ON HOLD until Paper Publication

	Authors:		Authors:

OCA: Protected "6dn6" [edit=sysop:move=sysop]

2018-06-14T05:46:39Z

Protected "6dn6" [edit=sysop:move=sysop]

←Older revision

Revision as of 05:46, 14 June 2018

OCA: New page: '''Unreleased structure''' The entry 6dn6 is ON HOLD Authors: Description: Category: Unreleased Structures

2018-06-14T05:46:36Z

New page: '''Unreleased structure''' The entry 6dn6 is ON HOLD Authors: Description: Category: Unreleased Structures

New page

'''Unreleased structure'''

The entry 6dn6 is ON HOLD

Authors:

Description:
[[Category: Unreleased Structures]]